Predicted Cervical Cancer Prevention: Impact of National HPV Vaccination Program on Young Women in South Korea
- PMID: 38228083
- PMCID: PMC11261207
- DOI: 10.4143/crt.2023.981
Predicted Cervical Cancer Prevention: Impact of National HPV Vaccination Program on Young Women in South Korea
Abstract
Purpose: This study aimed to evaluate the effectiveness of the national human papillomavirus (HPV) vaccination program of South Korea among its entire female population, particularly among younger age groups.
Materials and methods: We first predicted the incidence of cervical cancer over the next 20 years (2021-2040) using the Nordpred package based on Møller's age-period-cohort model under several scenarios for the national HPV vaccination program. We calculated the potential impact fractions and proportional differences under the current national vaccination programs, and alternative scenarios using the no-vaccination assumption as a reference.
Results: We estimated that the current national vaccination program would prevent 4.13% of cervical cancer cases and reduce the age-standardized incidence rate (ASR) by 8.79% in the overall population by 2036-2040. Under the alternative scenario of implementing the nine-valent vaccine, 5.13% of cervical cancer cases could be prevented and the ASR reduced by 10.93% during the same period. In another scenario, expanding the vaccination age to 9-17 years could prevent 10.19% of cervical cancer cases, with the ASR reduced by 18.57% during the same period. When restricted to ages < 40 years, the prevention effect was remarkably greater. We predict that the current national HPV program will reduce its incidence by more than 30% between 2036 and 2040 in women aged < 40 years.
Conclusion: The effectiveness of the vaccination program in reducing the incidence of cervical cancer was confirmed, with a considerable impact anticipated in younger age groups.
Keywords: Human papillomavirus viruses; Papillomavirus vaccines; Potential impact fraction; Uterine cervical neoplasms.
Conflict of interest statement
Conflict of interest relevant to this article was not reported.
Figures
Similar articles
-
Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.BMC Infect Dis. 2021 Jan 6;21(1):11. doi: 10.1186/s12879-020-05632-0. BMC Infect Dis. 2021. PMID: 33407188 Free PMC article.
-
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.Lancet Oncol. 2019 Mar;20(3):394-407. doi: 10.1016/S1470-2045(18)30836-2. Epub 2019 Feb 19. Lancet Oncol. 2019. PMID: 30795950
-
Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.BMC Public Health. 2020 May 12;20(1):671. doi: 10.1186/s12889-020-08840-0. BMC Public Health. 2020. PMID: 32398057 Free PMC article.
-
Current Status of Human Papillomavirus Infection and Introduction of Vaccination to the National Immunization Program in Korea: an Overview.J Korean Med Sci. 2018 Nov 28;33(52):e331. doi: 10.3346/jkms.2018.33.e331. eCollection 2018 Dec 24. J Korean Med Sci. 2018. PMID: 30584412 Free PMC article. Review.
-
Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.J Manag Care Pharm. 2010 Apr;16(3):217-30. doi: 10.18553/jmcp.2010.16.3.217. J Manag Care Pharm. 2010. PMID: 20331326 Free PMC article. Review.
References
-
- National Cancer Institution . Bethesda, MD: National Cancer Institution; c2022. Cervical cancer treatment [Internet] [cited 2022 Sep 12]. Available from: https://www.cancer.gov/types/cervical/patient/cervical-treatment-pdq#sec....
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. - PubMed
-
- Korea Central Cancer Registry. National Cancer Center . Goyang: National Cancer Cancer; c2022. Annual report of cancer statistics in Korea in 2020: National Cancer Control Project [Internet] [cited 2023 Mar 12]. Available from: http://ncc.re.kr/cancerStatsList.ncc?searchKey=total&searchValue=&pageNum=1.
-
- Korean Statistical Information Service . Daejeon: Statistics Korea; c2023. Cause of death statistics [Internet] [cited 2023 Mar 12]. Available from: https://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B34E09&vw_cd=M....
-
- Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002;346:1105–12. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical